Skip to main content

Table 2 Stratified analysis of the associations between rhinitis and depression

From: Cumulative evidence for association of rhinitis and depression

Variables

Allergic rhinitis and depression

p

Rhinitis and depression

p

Studies

OR (95% CI)

I2 (p-value)

Studies

OR (95% CI)

I2 (p-value)

Total

9

1.54 (1.24, 1.90)

78 (< 0.05)

 

6

1.86 (1.32, 2.62)

95.1 (< 0.05)

 

Study location

 Europe

1

2.65 (1.12, 6.28)

NA

< 0.05

2

2.61 (1.07, 6.37)

89.2 (< 0.05)

< 0.05

 Unites States

3

1.40 (0.88, 2.21)

85.1 (< 0.05)

 

2

1.85 (1.15, 2.96)

86.1 (< 0.05)

 

 Asia

4

1.60 (1.09, 2.33)

78.3 (< 0.05)

 

2

1.42 (0.96, 2.10)

82.5 (< 0.05)

 

 Other countries

1

2.5 (1.26, 4.97)

NA

 

0

NA

NA

 

Study design

 Cohort

2

2.15 (1.09, 4.25)

65.4 (> 0.05)

< 0.05

2

2.13 (1.71, 2.66)

42.9 (> 0.05)

> 0.05

 Cross-sectional

7

1.42 (1.14, 1.75)

76.9 (< 0.05)

 

4

1.75 (1.19, 2.55)

90 (< 0.05)

 

Sample size

 ≥ 10,000

4

1.41 (1.12, 1.78)

79.1 (< 0.05)

< 0.05

2

1.42 (0.96, 2.10)

82.5 (< 0.05)

< 0.05

 < 10,000

5

1.86 (1.08, 3.18)

80.6 (< 0.05)

 

4

2.10 (1.51, 2.90)

81.9 (< 0.05)

 

Sample population

 Adult

6

1.63 (1.17, 2.26)

75.7 (< 0.05)

> 0.05

4

1.93 (1.21, 3.10)

96.7 (< 0.05)

> 0.05

 < 18 years

3

1.64 (0.98, 2.77)

81.9 (< 0.05)

 

2

1.74 (1.42, 2.13)

0 (0.81)

 

Ascertainment of depression

 Self-report

6

1.34 (1.09, 1.65)

76.4 (< 0.05)

< 0.05

4

1.93 (1.21, 3.10)

96.7 (< 0.05)

> 0.05

 Diagnosed

3

2.19 (1.42, 3.38)

38.3 (> 0.05)

 

2

1.74 (1.42, 2.13)

0 (0.81)

 

Ascertainment of rhinitis

 Self-report

5

1.29 (1.05, 1.57)

77.4% (< 0.05)

< 0.05

5

1.88 (1.27, 2.77)

95.9 (< 0.05)

> 0.05

 Diagnosed

4

2.20 (1.56, 3.08)

14.3% (> 0.05)

 

1

1.8 (1.29, 2.51)

NA

 

Study quality

 NOS score > 5

6

1.6 (1.17, 2.18)

77.3% (< 0.05)

> 0.05

3

1.39 (1.09, 1.78)

70.4 (< 0.05)

< 0.05

 NOS score ≤ 5

3

1.79 (0.93, 1.90)

76.8% (< 0.05)

 

3

2.37 (1.66, 3.39)

80.1 (< 0.05)

 

Adjusted for confounding factors

 Minimal (≤ 7 factors)

6

1.56 (1.22, 1.99)

79.8 (< 0.05)

> 0.05

5

1.97 (1.32, 2.93)

96.1 (< 0.05)

< 0.05

 Substantial (≥ 8 factors)

3

1.54 (0.81, 2.94)

86.2 (< 0.05)

 

1

1.42 (1.03, 1.95)

NA

 

Adjusted for age

 Yes

4

1.43 (1.0, 2.03)

79.6% (< 0.05)

< 0.05

1

1.42 (1.03, 1.95)

NA

< 0.05

 No

5

1.9 (1.2, 3.01)

79.4% (< 0.05)

 

5

1.97 (1.32, 2.93)

96.1 (< 0.05)

 

Adjusted for sex

 Yes

6

1.71 (1.21, 2.42)

79.7% (< 0.05)

> 0.05

1

1.42 (1.03, 1.95)

NA

< 0.05

 No

3

1.44 (0.97, 2.15)

65% (> 0.05)

 

5

1.97 (1.32, 2.93)

96.1 (< 0.05)

 

Adjusted for asthma

 Yes

4

1.78 (0.97, 3.24)

85.7% (< 0.05)

> 0.05

1

1.42 (1.03, 1.95)

NA

< 0.05

 No

5

1.41 (1.14, 1.75)

71.3% (< 0.05)

 

5

1.97 (1.32, 2.93)

96.1 (< 0.05)

 

Adjusted for atopic dermatitis

 Yes

3

1.86 (1.41, 2.46)

2.6% (> 0.05)

< 0.05

0

NA

NA

NA

 No

6

1.38 (1.09, 1.74)

78.6% (< 0.05)

 

6

1.86 (1.32, 2.62)

95.1 (< 0.05)

 

Adjusted for household income

 Yes

3

1.69 (1.15, 2.49

68.5% (< 0.05)

> 0.05

0

NA

NA

NA

 No

6

1.55 (1.12, 2.13)

78% (< 0.05)

 

6

1.86 (1.32, 2.62)

95.1 (< 0.05)

 

Adjusted for comorbidities

 Yes

3

1.31 (0.83, 2.05)

78% (< 0.05)

> 0.05

1

1.42 (1.03, 1.95)

NA

< 0.05

 No

6

1.73 (1.31, 2.3)

82.4% (< 0.05)

 

5

1.97 (1.32, 2.93)

96.1 (< 0.05)

 
  1. A P-value <0.05 was considered significant